Clinical Trial

Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet

Study acronym: EHMet-DIA
Completed
View on ClinicalTrials.gov →
Summary
Lifestyle interventions based on diet and physical activity are the cornerstone of management for metabolic dysfunction-associated steatotic liver disease (MASLD), yet individual responses remain highly variable. Advanced imaging biomarkers and genetic profiling may help to characterize response patterns. This study aimed to evaluate the impact of a Mediterranean diet-based lifestyle intervention, with or without structured physical activity, on liver steatosis and fibrosis assessed by magnetic resonance imaging, and to identify determinants of treatment response.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-13.
Trial Details
NCT Number NCT07478588
Lead Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions MASLD
Enrollment 96 participants
Start Date 2022-06-01
Primary Completion 2023-02-23 (estimated)
Study Completion 2024-04-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-19